End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.94 CNY | -1.53% |
|
-11.15% | -11.47% |
05-24 | Mabwell Announces 9MW2821 Clinical Data | CI |
05-13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
Chart calendar Mabwell (Shanghai) Bioscience Co., Ltd.
Upcoming events on Mabwell (Shanghai) Bioscience Co., Ltd.
Past events on Mabwell (Shanghai) Bioscience Co., Ltd.
2024-06-03 09:00 | American Society of Clinical Oncology Meeting - Abstract No: 3013 |
2024-04-29 | Q1 2024 Earnings Release |
2024-04-09 16:30 | American Association for Cancer Research Meeting - Abstract Number: 6349 |
2024-04-09 16:30 | American Association for Cancer Research Meeting - Abstract Number: 6350 |
2024-04-08 | Q4 2023 Earnings Release |
2024-04-08 12:00 | American Association for Cancer Research Meeting - Abstract Number: 2365 |
2024-03-16 18:00 | Society of Gynecologic Oncology Meeting |
2024-03-13 | World Antibody-Drug Conjugate Conference |
2024-01-09 12:30 | JPMorgan Healthcare Conference |
2023-10-25 | Q3 2023 Earnings Release |
2023-10-19 | European Society for Medical Oncology Congress - Abstract Number: 3602 |
2023-10-19 | European Society for Medical Oncology Congress - Abstract Number: 4613 |
2023-08-06 | Q2 2023 Earnings Release |
2023-04-24 | Q1 2023 Earnings Release |
2023-04-06 | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 128 247 -48.37% | 335 |
EBITDA Million CNY | Released Forecast Spread | 0,00 | -973 -818 -19.02% | -805 |
EBIT Million CNY | Released Forecast Spread | 0,00 | -1 053 -947 -11.16% | -940 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -1 056 -914 -15.51% | -921 |
Net income Million CNY | Released Forecast Spread | -954 | -1 053 -912 -15.53% | -919 |
EPS CNY | Released Forecast Spread | -2,44 | -2,64 -2,28 -15.62% | -2,30 |
Announcement Date | 20/02/23 | 23/02/24 | - |
Past sector events for Mabwell (Shanghai) Bioscience Co., Ltd.
2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688062 Stock
- Calendar Mabwell (Shanghai) Bioscience Co., Ltd.